Before you watch this webinar
Enhancing your learning experience begins with understanding you better. Collecting data enables us to tailor our educational content specifically for our audience. Discover more about how we handle your information in our Privacy Policy.
This area of the website is reserved for healthcare professionals as it contains information created for a healthcare professional audience.
Event
Implementing the 2024 MS diagnostic criteria: what earlier detection means for UK services
Please note: There is restricted access to the live webinars. Access to the live webinars is for healthcare professionals and a limited number of pharmaceutical representatives. If you are not granted access to the live webinar, you will be able to review the footage, which will be posted on our website shortly after the webinar has been conducted.
Our sponsor

This activity has been financially supported by sponsorship from Juvisé Pharmaceuticals. The sponsor has had no control over the educational content or organisation of this activity.
Join us for our next live webinar on Monday, 22nd June at 17:15 BST. You are invited to watch the webinar from your computer or tablet. We will be live for 1 hour via Zoom and a recording will be available following the meeting.
Overview
The 2024 revisions to the McDonald diagnostic criteria are enabling earlier and more confident MS diagnoses — but they also bring significant implications for UK MS services. Earlier identification is likely to increase demand across neurology, radiology and treatment pathways, requiring centres to adapt quickly, safely and sustainably.
This webinar focuses on the practical realities of implementing the updated criteria. We will explore how services can redesign diagnostic pathways, manage rising capacity pressures, and make evidence based treatment decisions for individuals diagnosed earlier or with minimal symptoms. The session will also address how to communicate diagnostic uncertainty in a way that supports patient understanding and shared decision making.
Designed for MS clinicians, nurses, AHPs and service managers, this session will help you understand what these changes mean for day to day practice — and how your service can respond effectively.
Objectives
- Implement the updated 2024 MS diagnostic criteria within your centre, including practical steps, governance considerations and common pitfalls
- Anticipate and manage increased demand on neurology, radiology and treatment pathways resulting from earlier and expanded diagnosis
- Apply structured, evidence based approaches to treatment decision making for individuals diagnosed earlier or with minimal symptoms
- Use effective communication strategies to explore diagnostic uncertainty with patients in a clear, compassionate and comprehensible way
This event is free to attend as a result of sponsorship from our sponsors. The current event sponsors are listed on this page. In the interest of Neurology Academy and our sponsors’ legitimate business interests, we make available your name, job title and workplace to our sponsors. It allows us to attract the most appropriate sponsors, delegates and speakers for the events and to facilitate potential collaboration and communication between you and the sponsors; and allows us to offer other relevant events and services to the healthcare and life science industries. You can ask us not to share your your name, job title and workplace by emailing info@neurologyacademy.org. We respect the privacy of every person for whom we have personal data. The group privacy and cookies policy can be viewed here.
Book your place now
Our sponsor

This activity has been financially supported by sponsorship from Juvisé Pharmaceuticals. The sponsor has had no control over the educational content or organisation of this activity.
CPD accreditation
We will apply for CPD accreditation from the Royal College of Physicians for this webinar.
Chair
Dr Kate PetheramConsultant neurologist, South Tyneside & Sunderland NHS Foundation Trust
Speakers
Ruth StrossDirector of services and health professional lead, MS Trust
Associate Prof Tarunya ArunConsultant neurologist, University Hospitals Coventry and Warwickshire NHS Trust
Dr Christine LonginottiHighly specialist clinical psychologist, Chelsea & Westminster NHS Foundation Trust
Encouraging excellence, developing leaders, inspiring change
MS Academy was established in 2016 and in that time has accomplished a huge amount with exciting feedback demonstrating delegates feel inspired and energised along their personal and service development journeys. The various different levels of specialist MS training we offer are dedicated to case-based learning and practical application of cutting edge research.